Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Minssen

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Drug Development Research|March 12, 2019
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?R Neethu, Timo Minssen
Personalized Medicine|May 16, 2018
Legal aspects of biobanking as key issues for personalized medicine and translational exploitationTimo Minssen, Jens Schovsbo
Drug Discovery Today|January 13, 2018
Unlocking the full potential of open innovation in the life sciences through a classification systemNiclas Nilsson, Timo Minssen
Nature Biotechnology|July 9, 2015
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?W Nicholson Price, Timo Minssen
Medical Law Review|July 2, 2020
When Does Stand-Alone Software Qualify as a Medical Device in the European Union?-The Cjeu's Decision in Snitem and What it Implies for the Next Generation of Medical DevicesTimo Minssen, Marc Mimler, Vivian Mak
European Journal of Health Law|August 15, 2023
Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI PerspectivesSanta Slokenberga, Timo Minssen, Ana Nordberg
European Journal of Health Law|August 15, 2023
Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent LawDuncan Matthews, Timo Minssen, Ana Nordberg
Journal of Medical Ethics|February 9, 2026
From AI SIM to AI twinning: a spectrum of digital representations of personsMark Fenwick, Paulius Jurcys, Timo Minssen
NPJ Digital Medicine|September 6, 2024
Navigating the EU AI Act: implications for regulated digital medical productsMateo Aboy, Timo Minssen, Effy Vayena
JAMA|July 6, 2023
The Challenges for Regulating Medical Use of ChatGPT and Other Large Language ModelsTimo Minssen, Effy Vayena, I Glenn Cohen
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Drug Development Research|March 12, 2019
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?R Neethu, Timo Minssen
Personalized Medicine|May 16, 2018
Legal aspects of biobanking as key issues for personalized medicine and translational exploitationTimo Minssen, Jens Schovsbo
Drug Discovery Today|January 13, 2018
Unlocking the full potential of open innovation in the life sciences through a classification systemNiclas Nilsson, Timo Minssen
Nature Biotechnology|July 9, 2015
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?W Nicholson Price, Timo Minssen
Medical Law Review|July 2, 2020
When Does Stand-Alone Software Qualify as a Medical Device in the European Union?-The Cjeu's Decision in Snitem and What it Implies for the Next Generation of Medical DevicesTimo Minssen, Marc Mimler, Vivian Mak
European Journal of Health Law|August 15, 2023
Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI PerspectivesSanta Slokenberga, Timo Minssen, Ana Nordberg
European Journal of Health Law|August 15, 2023
Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent LawDuncan Matthews, Timo Minssen, Ana Nordberg
Journal of Medical Ethics|February 9, 2026
From AI SIM to AI twinning: a spectrum of digital representations of personsMark Fenwick, Paulius Jurcys, Timo Minssen
NPJ Digital Medicine|September 6, 2024
Navigating the EU AI Act: implications for regulated digital medical productsMateo Aboy, Timo Minssen, Effy Vayena
JAMA|July 6, 2023
The Challenges for Regulating Medical Use of ChatGPT and Other Large Language ModelsTimo Minssen, Effy Vayena, I Glenn Cohen
Pageof 7